[go: up one dir, main page]

UA87836C2 - METHOD OF OBTAINING PURE, SAFETY FROM THE VIRUSOLOGICAL POINT OF VIEW OF ANTIBODIES - Google Patents

METHOD OF OBTAINING PURE, SAFETY FROM THE VIRUSOLOGICAL POINT OF VIEW OF ANTIBODIES

Info

Publication number
UA87836C2
UA87836C2 UAA200610282A UAA200610282A UA87836C2 UA 87836 C2 UA87836 C2 UA 87836C2 UA A200610282 A UAA200610282 A UA A200610282A UA A200610282 A UAA200610282 A UA A200610282A UA 87836 C2 UA87836 C2 UA 87836C2
Authority
UA
Ukraine
Prior art keywords
solution
antibodies
virus
resin
heplanoale
Prior art date
Application number
UAA200610282A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Андреа Бухахер
Гюнтер Иберер
Юрген Рьёмиш
Original Assignee
Октафарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34910983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA87836(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Октафарма Аг filed Critical Октафарма Аг
Publication of UA87836C2 publication Critical patent/UA87836C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2103/05—

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method of preparing a purified, virus inactivated and virus safe antibody preparation from a starling solution comprising antibodies and contaminants, the method comprising the steps of: (a) adjusting the pH of the starting solution to about 4.6 to about 4-95 in particular to about 4.8 to about 4.95 to produce an intermediate solution; (b) adding caprylale and/or heplanoale ions to the intermediate solution and maintaining the pH at about 4.6 to about 4.95 in particular pH at about 4.8 to about 4.95, whereby a precipitate is formed and the antibodies are essentially present in the supernatant; (c) incubating the supematant solution under conditions of caprylale and/or heplanoale ion concentration, lime, pH and temperature optionally concentrating and diafiltrating the filtrated solution before pH adjustment; (d) applying the filtered solution with a least one anion exchange resin and optionally with two different anion exchanae resins under conditions that allow binding of contaminants to the resin while not allowing significant binding' of the antibodies to the resin, wherein a purified, virus inactivated and virus safe antibody preparation is produced.
UAA200610282A 2004-02-27 2005-02-25 METHOD OF OBTAINING PURE, SAFETY FROM THE VIRUSOLOGICAL POINT OF VIEW OF ANTIBODIES UA87836C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54810704P 2004-02-27 2004-02-27

Publications (1)

Publication Number Publication Date
UA87836C2 true UA87836C2 (en) 2009-08-25

Family

ID=34910983

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200610282A UA87836C2 (en) 2004-02-27 2005-02-25 METHOD OF OBTAINING PURE, SAFETY FROM THE VIRUSOLOGICAL POINT OF VIEW OF ANTIBODIES

Country Status (18)

Country Link
US (1) US7553938B2 (en)
EP (2) EP1718675B2 (en)
JP (1) JP5042817B2 (en)
KR (1) KR101206788B1 (en)
CN (1) CN1922207B (en)
AU (1) AU2005217148B2 (en)
BR (1) BRPI0508096B8 (en)
CA (1) CA2557229C (en)
DK (1) DK1718675T3 (en)
ES (1) ES2407380T5 (en)
IL (1) IL177541A (en)
NO (1) NO20063784L (en)
PL (1) PL1718675T3 (en)
PT (1) PT1718675E (en)
RU (1) RU2337109C2 (en)
UA (1) UA87836C2 (en)
WO (1) WO2005082937A2 (en)
ZA (1) ZA200607119B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc Methods for purifying antibodies using ceramic hydroxyapatite
JP5505853B2 (en) 2007-02-13 2014-05-28 味の素株式会社 Virus inactivation method using slightly acidic arginine as an additive
WO2009118331A1 (en) * 2008-03-28 2009-10-01 Research Foundation For Medical Devices Method of viral inactivation of biological fluids by solvent/detergent-treatment
WO2010138736A2 (en) 2009-05-27 2010-12-02 Baxter International Inc. A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
EP2399613A1 (en) * 2010-06-22 2011-12-28 Research Foundation For Medical Devices Fractionation of plasma using caprylic acid
WO2012051147A1 (en) * 2010-10-11 2012-04-19 Abbott Laboratories Processes for purification of proteins
RU2013121589A (en) 2010-10-13 2014-11-20 Октафарма Аг METHOD FOR CLEANING THE KEY FACTOR N
TR201807926T4 (en) 2011-02-04 2018-06-21 Octapharma Ag The method of inactivating / removing coagulation factors by precipitation.
FR2977893B1 (en) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement PROCESS FOR PREPARING A CONCENTRATE OF MULTIPURPOSE IMMUNOGLOBULINS
CN102286099B (en) * 2011-08-05 2014-04-09 深圳市卫光生物制品股份有限公司 Human cytomegalovirus immunoglobulin for intravenous injection and preparation method thereof
TWI629283B (en) 2012-02-23 2018-07-11 巴克斯歐塔公司 Fraction i-iv-1 precipitation of immunoglobins from plasma
ES2755056T3 (en) 2012-02-29 2020-04-21 IgG-stimulated remyelination of peripheral nerves
EP2855504B1 (en) * 2012-05-31 2018-10-24 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
CN102757496B (en) * 2012-06-07 2014-06-18 山东泉港药业有限公司 Method for purifying and preparing anti-VEGF antibody fragment
LT2864346T (en) * 2012-06-21 2019-01-25 Synthon Biopharmaceuticals B.V. Method of purifying an antibody
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
EP2961763A4 (en) * 2013-02-28 2016-10-12 Agency Science Tech & Res CHROMATOGRAPHIC PURIFICATION OF ANTIBODIES FROM CULTIVATED CROPS OF CHROMATIN-DEFICIENT CELLS
HK1219964A1 (en) 2013-03-08 2017-04-21 Genzyme Corporation Continuous purification of therapeutic proteins
KR102114021B1 (en) * 2013-03-15 2020-05-22 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 Methods for purifying antibodies
KR20160068972A (en) 2013-11-15 2016-06-15 노파르티스 아게 Removal of residual cell culture impurities
RU2561596C2 (en) * 2013-12-18 2015-08-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Method for producing virus-inactivated immunoglobulin solutions low in residual caprylic acid
TWI709570B (en) 2014-01-17 2020-11-11 美商健臻公司 Sterile chromatography and manufacturing processes
TWI709569B (en) 2014-01-17 2020-11-11 美商健臻公司 Sterile chromatography resin and use thereof in manufacturing processes
KR20160118369A (en) * 2014-02-27 2016-10-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Antibody purification process
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
EP3842108A1 (en) * 2014-04-30 2021-06-30 Novo Nordisk A/S Methods for the purification of proteins using caprylic acid
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
WO2015195453A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
CN115463546A (en) 2014-06-25 2022-12-13 Emd 密理博公司 Filter element, tangential flow filtration system, method of producing a feed screen
EP3010626B1 (en) 2014-08-29 2022-12-14 EMD Millipore Corporation Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
KR102079585B1 (en) 2014-08-29 2020-02-21 이엠디 밀리포어 코포레이션 Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
ES2964640T3 (en) 2015-08-13 2024-04-08 Amgen Inc Depth filtration loaded with antigen-binding proteins
PT3135687T (en) 2015-08-31 2019-05-21 Inst Grifols S A Method for the preparation of immunoglobulins
ES2925059T3 (en) 2016-06-09 2022-10-13 Emd Millipore Corp Radial path filter elements, systems and methods of use thereof
ES2770674T3 (en) 2016-06-10 2020-07-02 Octapharma Ag High concentration immunoglobulin composition for pharmaceutical applications
IT201600079328A1 (en) * 2016-07-28 2018-01-28 Altergon Sa Improved method for the decontamination of biological material by partition and inactivation
DK3510042T3 (en) 2016-09-07 2024-06-10 Glaxosmithkline Ip Dev Ltd Method for purification of antibodies
JP6370853B2 (en) * 2016-09-26 2018-08-08 インスティトゥト グリフォルス，ソシエダ アノニマ Method for preparing immunoglobulin
RU2708394C2 (en) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Method of producing immunoglobulins
AU2019270458B2 (en) 2018-05-17 2026-01-22 Csl Behring Ag Method and system of protein extraction
EP3843869A1 (en) 2018-08-31 2021-07-07 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
CN110627892B (en) * 2019-09-05 2023-04-14 江苏康禾生物制药有限公司 Preparation method of recombinant human thrombopoietic factor stock solution
CN110590931B (en) * 2019-09-05 2023-04-07 江苏康禾生物制药有限公司 Method for removing and/or inactivating virus in recombinant human thrombopoietin stock solution
MX2022011950A (en) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co METHOD FOR PRODUCING AN IMMUNOGLOBULIN PREPARATION FROM PLASMA WITH REDUCTION OF THE C-1 INHIBITOR.
CN111991571B (en) * 2020-08-12 2022-04-05 湖州师范学院 A kind of method of low pH virus inactivation on column
JP7606185B2 (en) * 2020-09-03 2024-12-25 日機装株式会社 Phenol red adsorbent and method for removing phenol red
EP4271706A4 (en) * 2020-12-28 2025-01-15 Plasma Technologies LLC Systems and methods for process scale isolation of immunoglobulin g
IL308819A (en) * 2021-05-26 2024-01-01 Csl Behring Ag Plasma fractionation by continuous extraction
BE1029863B1 (en) * 2022-05-10 2023-05-12 Prothya Biosolutions Belgium METHODS FOR PRODUCING IMMUNOGLOBULIN G (IgG) PREPARATIONS AND/OR SOLUTIONS
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU836831A1 (en) * 1978-07-19 1982-04-23 Научно-исследовательский институт эпидемиологии и микробиологии Method for preparing immunoglobulin preparation
CA1201063A (en) 1982-07-20 1986-02-25 Winnipeg Rh Institute Inc., (The) Process for preparing purified immune globulin (igg)
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8807380D0 (en) 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
US4939176A (en) 1988-12-20 1990-07-03 Miles Inc. Viral inactivation process
DE4125625C2 (en) 1991-08-02 1999-12-02 Octapharma Ag Glarus Process for the preparation of virus-inactivated immunoglobulin solutions
WO1997003706A1 (en) 1995-07-14 1997-02-06 Croix-Rouge De Belgique Method and apparatus for inactivating contaminants in blood products
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
CN1151174C (en) * 1998-12-21 2004-05-26 蒋盘宏 Process for preparing antiglobulin of human lymphocyte
US20070244305A1 (en) * 2004-01-30 2007-10-18 Suomen Punainen Risti Veripalvelu Process for The Manufacture of Virus Safe Immunoglobulin

Also Published As

Publication number Publication date
AU2005217148A1 (en) 2005-09-09
EP1718675B2 (en) 2017-01-25
IL177541A0 (en) 2006-12-10
DK1718675T3 (en) 2013-07-15
BRPI0508096B8 (en) 2021-05-25
EP1718675A2 (en) 2006-11-08
PT1718675E (en) 2013-05-21
KR101206788B1 (en) 2012-11-30
PL1718675T3 (en) 2013-09-30
IL177541A (en) 2014-09-30
NO20063784L (en) 2006-09-25
WO2005082937A3 (en) 2005-11-17
CA2557229A1 (en) 2005-09-09
JP5042817B2 (en) 2012-10-03
EP2277915A1 (en) 2011-01-26
ES2407380T3 (en) 2013-06-12
CA2557229C (en) 2012-07-10
AU2005217148B2 (en) 2011-09-08
KR20060131920A (en) 2006-12-20
CN1922207B (en) 2012-06-06
RU2337109C2 (en) 2008-10-27
BRPI0508096A (en) 2007-07-17
CN1922207A (en) 2007-02-28
RU2006134285A (en) 2008-04-10
WO2005082937A2 (en) 2005-09-09
JP2007533660A (en) 2007-11-22
BRPI0508096B1 (en) 2019-04-02
US20070173638A1 (en) 2007-07-26
US7553938B2 (en) 2009-06-30
EP1718675B1 (en) 2013-04-10
ZA200607119B (en) 2007-04-25
ES2407380T5 (en) 2017-07-07

Similar Documents

Publication Publication Date Title
UA87836C2 (en) METHOD OF OBTAINING PURE, SAFETY FROM THE VIRUSOLOGICAL POINT OF VIEW OF ANTIBODIES
DE60139467D1 (en) PROCESS FOR PREPARING PROTEINS WITH REDUCTION OF MANNOSEPHOSPHATE IN THE SUGAR CHAIN AND THE GLYCOPROTEIN MADE THEREOF
ATE321781T1 (en) METHOD FOR PRODUCING A PROTEIN CONTAINING FRACTION ENRICHED WITH BETA-TGF IN ACTIVATED FORM, AND THE FRACTION SO OBTAINED AND THE THERAPEUTIC USES THEREOF
DK1320410T3 (en) Bipolar membrane electrodialysis of multivalent metal salts
JPH1129494A5 (en)
DE69634360D1 (en) METHODS OF INCREASING THE PRODUCTION OF VIRAL IMPORTS IN CELL CULTURE BY SUPPRESSING INTERFERON
DE58903874D1 (en) INTEGRAL ASYMMETRICAL POLYAETHERSULPHONE MEMBRANE, METHOD FOR THE PRODUCTION AND USE FOR ULTRAFILTRATION AND MICROFILTRATION.
CA2239237A1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
DE69739234D1 (en) NEW ESCHERICHIA COLI-STRAINS, METHODS FOR THEIR MANUFACTURE AND USE THEREOF IN FERMENTATION PROCESSES FOR THE PRODUCTION OF L-THREONINE
DK121683A (en) PROCEDURE FOR PREPARING IMMUNOENZYMATIC CONJUGATES
ES8706777A1 (en) Stabilized natural pigment complexes.
DK1151007T3 (en) Process for the preparation of a fibrinogen and fibronectin-based preparation as well as protein compositions prepared thereby
WO2001026682A3 (en) Modified plant viruses and methods of use thereof
ATE278706T1 (en) METHOD FOR CONCENTRATING INSOLUBLE PROTEIN USING VIBRATING MEMBRANES FILTRATION
EP1147712A3 (en) Method for producing milk calcium composition
SG10201803982TA (en) Antibodies and processes for preparing the same
ATE138923T1 (en) METHOD FOR PRODUCING PURIFIED GLYCOLIPIDES BY MEMBRANE SEPARATION PROCESS
AU537881B2 (en) Diamine-epichlorohydrin polycondensates
CA2407559A1 (en) Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
DE60124526D1 (en) METHOD FOR IDENTIFYING HELICOBACTER ANTIGENES
DE50307815D1 (en) FILM COVERS WITH VERY CONTROLLED RELEASE AND HIGH STABILITY
DK1165489T3 (en) Process for the preparation of gabapentin
DK1718673T3 (en) A process for purifying albumin comprising a nanofiltration step, solution and composition for therapeutic use containing
DK1165615T3 (en) Monoclonal antibodies to human protein Mcm3, process for their preparation of their use
WO2001004143A3 (en) Prostase vaccine